TickerGuard
Buy Day today: Neutral (48) Mixed market breadth · no major macro event
AMRN

Amarin Corporation PLC

Healthcare · Drug Manufacturers - General

13.30$ +0.4% vs. previous close Closing price · As of: Sep 28, 2026

Statements

Balance Sheet

Amarin Corporation PLC (AMRN) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Total Assets" came in at 671 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet AMRN
Line item 1996 1997 1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
45 40 17 34 49 91 98 47 24 47 49 42 37 56 35 126 311 252 171 173 167 162 386 882 966 1,068 886 832 685 671
21 22 6.3 12 25 42 48 15 13 37 40 22 16 56 33 119 286 219 145 144 146 153 378 855 879 879 689 725 595 650
4.8 5.6 0.8 1.6 2.0 30 24 2.1 11 34 37 18 11 52 31 117 260 192 120 107 98 74 249 645 187 219 218 199 121 135
4.8 5.6 0.8 1.6 2.0 30 24 2.1 11 34 37 18 11 52 31 117 260 192 120 107 98 74 249 645 501 454 309 321 294 303
15 7.4 3.6 6.9 4.3 7.2 15 1.3 1.3 2.1 1.6 1.7 0.7 1.2 – – 0.9 3.6 7.8 14 20 45 67 116 155 164 131 134 122 127
1.4 1.3 1.1 3.4 2.8 3.6 7.7 2.7 – – 0.4 0.9 – – – – 21 21 14 19 21 30 58 77 189 235 229 259 166 196
– – – – 1.4 2.2 2.4 1.0 0.4 0.5 0.3 0.6 0.6 0.1 0.1 0.4 0.8 0.6 0.4 0.2 0.1 0.0 0.1 11 10 9.1 9.9 – – –
– – – – – – – – – – – – – – – – – – – – – – – – – – – – – 13
9.2 8.7 4.0 20 23 47 48 32 10 9.6 9.0 20 20 20 – – 11 11 10 9.4 8.8 8.1 7.5 15 14 24 22 19 16 13
22 26 30 22 17 61 104 54 7.0 8.2 11 18 7.8 7.6 238 132 315 286 260 303 176 227 233 274 339 401 291 280 199 211
8.1 23 21 20 4.5 54 67 54 4.3 8.0 11 15 7.1 6.7 7.6 8.5 25 38 40 51 76 109 157 242 307 371 259 259 180 194
0.2 13 7.6 9.1 0.2 45 28 32 – 0.0 – 0.0 – 1.0 – – – 13 15 15 31 23 34 50 170 208 10 – – –
2.0 2.9 8.4 3.6 1.8 3.0 3.1 3.6 1.1 0.8 2.1 3.5 2.0 2.5 4.4 4.4 17 6.4 8.5 11 6.1 25 38 50 106 115 65 53 40 45
– – – – 9.5 6.5 22 – 2.0 0.0 – 2.1 0.0 0.0 – 0.0 219 237 211 236 85 100 46 – – – – – – –
23 15 -14 12 31 30 -6.2 -6.3 17 39 38 24 29 49 -202 -6.0 -4.0 -34 -88 -129 -9.1 -65 152 608 628 667 595 552 486 459
-12 -22 -50 -46 -38 -42 -85 -106 -101 -120 -144 -185 -204 -271 -499 -568 -748 -914 -970 -1,119 -1,204 -1,272 -1,389 -1,411 -1,429 -1,421 -1,527 -1,586 -1,669 -1,707
0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.1 0.2 0.4 0.5 22 2.1 5.0 6.5 7.2 8.4 8.7 181 11 14 15 17 19 20 20 20 21 21

Data as of: September 28, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?